Top Health Tools
Top Health Tools

Top Reports
Top Reports
Top Articles
Top Articles

Top Reviews
Top Reviews
FDA Expands Use of Untested
H1N1 Vaccines to Infants and Children

The U.S. Food and Drug Administration has extended its sadistic badge of approval on untested CSL Ltd H1N1 influenza vaccines to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

The company’s 2009 H1N1 vaccine was approved based on the same unfounded and irresponsible testing protocols that have taken the drug industry by storm in the face of speedy approvals to rush pandemic vaccinations worldwide.

Firstly, the National Institute for Allergies and Infectious Disease conducted a study which showed that 75% of children under 35 months of age received absolutely no protection from the H1N1 vaccine. In addition 64% of children between 3 to 9 years old received no protection from the vaccine.

It should also be noted that the standard to test any vaccine is to first produce exposure to the virus and subsequently prevent the infection. This is the only scientifically established method of concluding the efficacy of any vaccine. No H1N1 vaccine has ever been tested using this protocol and all H1N1 vaccines have therefore been approved using scientific fraud!

CSL's PANVAX Vaccine contains immunotoxins, neurotoxins and carcinogens including beta-propiolactone (carcinogen), neomycin (immunotoxin), sodium taurodeoxycholate (carcinogen/immunotoxin), polymyxin (neurotoxin) and thimerosal (neurotoxin).

See Report - The Goal of Every H1N1 Swine Flu Vaccine

The CSL's Afluria H1N1 Influenza Vaccine contains almost identical concentrations of these toxins.

An ongoing study by CSL's 2009 H1N1 Influenza Vaccine in Healthy Children is still ongoing with no conclusive results.

Another study on CSL's 2009 H1N1 Influenza Vaccine in healthy pediatric US populations is also ongoing with no conclusive results.

There is also a trial (still not open for participant recruitment) on the CSL H1N1 Influenza Vaccine with and without AS03 adjuvant, which has again offered no conclusive results.

The approval for the H1N1 vaccine being extended to children was not based on any H1N1 vaccine trial but on a study of CSL's seasonal flu vaccine in children. The FDA is using these findings to justify inoculating children across America with the H1N1 vaccine, a criminal behavior at the highest levels of medical science.

Common adverse events experienced by children after administration of seasonal and H1N1 vaccines typically include , pain, redness, swelling, fatigue, headaches, arthralgia (joint inflammation), myalgia (muscle inflammation), shivering, sweating, swollen lymph nodes, fever, vomiting, tingling or numbness of the hands or feet, shortness of breath, vasculitis (inflammation of the blood vessels).

As with any medical product, serious adverse events may occur such as blood and lymphatic system disorders (lymphadenopathy), psychiatric disorders (insomnia), nervous system disorders (dizziness, paraesthesia, inflammation of the central nervous system, inflammation of nerves, autoimmune disorders affecting myelin sheaths of nerves such as Guillain-Barré Syndrome), ear and labyrinth disorders (vertigo), respiratory, thoracic and mediastinal disorders (dyspnoea), gastrointestinal disorders (nausea, diarrhea, abdominal pain, vomiting, dyspepsia, stomach discomfort), skin and subcutaneous tissue disorders (pruritus, rash), musculoskeletal and connective tissue disorders (back pain, musculoskeletal stiffness, neck pain, muscle spasms, pain in extremity), general disorders and administration site conditions (bruising, asthenia, chest pain, malaise).

The FDA says it is collaborating with the U.S. Department of Health and Human Services, including the Centers for Disease Control and Prevention, and other government agencies to enhance the capacity for adverse event safety monitoring during and after the 2009 H1N1 vaccination program, which could tally into tens of thousands if not more.

Ironically, CSL Ltd states that the vaccines are preservative-free even though they contain thimerosal, a mercury derivative which is a neurotoxin and potentially lethal preservative.

Both vaccines approved are manufactured by CSL Ltd. of Australia.

Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.

Reference Source
November 13, 2009


STAY CONNECTEDNewsletter | RSS | Twitter | YouTube |
This site is owned and operated by 1999-2018. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
volunteerDonateWrite For Us
Stay Connected With Our Newsletter